Could molecular studies save Hydroxyethyl starch from total disappearance?
Journal of Cellular & Molecular Anesthesia,
Vol. 3 No. 4 (2018),
22 February 2019
,
Page 155-158
https://doi.org/10.22037/jcma.v3i4.24282
Abstract
Up until now, hydroxyethyl starch (HES) solutions have mainly been indicated as "volume expanders". Recent unfavorable reports of these solutions such as probability of kidney injury or inducing coagulopathy have relatively ejected these solutions in many centers, particularly in European countries. Despite several confirming studies, multiple anecdotal letters or reviews has challenged total disappearance of these colloids from medicine practice. Also, some novel observations emphasized the distinguished ability of HES to preserve the microvascular integrity even at the presence of an inflammatory process. Despite extreme statements has been published demanding immediate suspension of these fluids from the market, it seems logical to revise the most recent studies which may declare new pathways to approach HES family of solutions.
- Colloid
- Hydroxyethyl starch
- fluid resuscitation
- HES
- Glycocalyx
How to Cite
References
Laake JH, Tonnessen TI, Chew MS, Lipcsey M, Hjelmqvist H, Wilkman E, et al. The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency. Acta Anaesthesiol Scand. 2018;62(6):874-5.
[European Medicines Agency 11//2013: Annex III Amendments to Relevant Sections of the Summary of Product Characteristics and Package Leaflet Under Article 107i. Available online at: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Hydroxyethyl_starch-containing_medicines_107/Position_provided_by_CMDh/WC500153120.pdf].
Cohen D. EMA calls for hydroxyethyl starch solutions to be taken off market. BMJ. 2018;360:k225.
Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-39.
Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367(20):1901-11.
Roberts I, Shakur H, Bellomo R, Bion J, Finfer S, Hunt B, et al. Hydroxyethyl starch solutions and patient harm. Lancet. 2018;391(10122):736.
Bellomo R, Bion J, Finfer S, Myburgh J, Perner A, Reinhart K. Open Letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Acta Anaesthesiol Scand. 2014;58(3):365-70.
Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev. 2013(7):CD007594.
Lewis SR, Pritchard MW, Evans DJ, Butler AR, Alderson P, Smith AF, et al. Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev. 2018;8:CD000567.
Priebe HJ. Should hydroxyethyl starch be banned? Lancet. 2018;392(10142):117-8.
Weiss R, Wenk M, Van Aken H, Zwissler B, Chappell D, Zarbock A. HES or How to End Science. Anesth Analg. 2018;127(6):1440-4.
Ferreira DA, Cruz R, Venancio C, Faustino-Rocha AI, Silva A, Mesquita JR, et al. Evaluation of renal injury caused by acute volume replacement with hydroxyethyl starch 130/0.4 or Ringer's lactate solution in pigs. J Vet Sci. 2018;19(5):608-19.
He B, Xu B, Xu X, Li L, Ren R, Chen Z, et al. Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials. Crit Care. 2015;19:92.
Li L, Li Y, Xu X, Xu B, Ren R, Liu Y, et al. Safety evaluation on low-molecular-weight hydroxyethyl starch for volume expansion therapy in pediatric patients: a meta-analysis of randomized controlled trials. Crit Care. 2015;19:79.
Li N, Statkevicius S, Asgeirsson B, Schott U. Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery. Perioper Med (Lond). 2015;4:9.
Nilsson CU, Strandberg K, Engstrom M, Reinstrup P. Coagulation during elective neurosurgery with hydroxyethyl starch fluid therapy: an observational study with thromboelastometry, fibrinogen and factor XIII. Perioper Med (Lond). 2016;5:20.
Nielsen VG. High-molecular-weight hydroxyethyl starch accelerates kallikrein-dependent clot initiation. J Trauma. 2007;62(6):1491-4.
Peng Y, Du J, Zhao X, Shi X, Wang Y. Effects of colloid pre-loading on thromboelastography during elective intracranial tumor surgery in pediatric patients: hydroxyethyl starch 130/0.4 versus 5% human albumin. BMC Anesthesiol. 2017;17(1):62.
Feix JA, Peery CA, Gan TJ, Warner DS, James ML, Zomorodi A, et al. Intra-operative hydroxyethyl starch is not associated with post-craniotomy hemorrhage. Springerplus. 2015;4:350.
Ghodraty MR, Rokhtabnak F, Dehghan HR, Pournajafian A, Baghaee Vaji M, Koleini ZS, et al. Crystalloid versus colloid fluids for reduction of postoperative ileus after abdominal operation under combined general and epidural anesthesia. Surgery. 2017;162(5):1055-62.
Joosten A, Delaporte A, Ickx B, Touihri K, Stany I, Barvais L, et al. Crystalloid versus Colloid for Intraoperative Goal-directed Fluid Therapy Using a Closed-loop System: A Randomized, Double-blinded, Controlled Trial in Major Abdominal Surgery. Anesthesiology. 2018;128(1):55-66.
Kimberger O, Arnberger M, Brandt S, Plock J, Sigurdsson GH, Kurz A, et al. Goal-directed colloid administration improves the microcirculation of healthy and perianastomotic colon. Anesthesiology. 2009;110(3):496-504.
Margraf A, Herter JM, Kuhne K, Stadtmann A, Ermert T, Wenk M, et al. 6% Hydroxyethyl starch (HES 130/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice. Crit Care. 2018;22(1):111.
Pries AR, Kuebler WM. Normal endothelium. Handb Exp Pharmacol. 2006(176 Pt 1):1-40.
Lipowsky HH. Microvascular rheology and hemodynamics. Microcirculation. 2005;12(1):5-15.
Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, oude Egbrink MG. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 2007;454(3):345-59.
Torres LN, Chung KK, Salgado CL, Dubick MA, Torres Filho IP. Low-volume resuscitation with normal saline is associated with microvascular endothelial dysfunction after hemorrhage in rats, compared to colloids and balanced crystalloids. Crit Care. 2017;21(1):160.
Job KM, O'Callaghan R, Hlady V, Barabanova A, Dull RO. The Biomechanical Effects of Resuscitation Colloids on the Compromised Lung Endothelial Glycocalyx. Anesth Analg. 2016;123(2):382-93.
Wiedermann CJ. Reporting bias in trials of volume resuscitation with hydroxyethyl starch. Wien Klin Wochenschr. 2014;126(7-8):189-94.
Li J, Wang B, Wang S, Mu F. Effects of hypertonic saline - hydroxyethyl starch and mannitol on serum osmolality, dural tension and hemodynamics in patients undergoing elective neurosurgical procedures. Int J Clin Exp Med. 2014;7(8):2266-72.
Choi SJ, Ahn HJ, Chung SS, Kim MH, Choi DH, Lee SM, et al. Hemostatic and electrolyte effects of hydroxyethyl starches in patients undergoing posterior lumbar interbody fusion using pedicle screws and cages. Spine (Phila Pa 1976). 2010;35(7):829-34.
Entholzner EK, Mielke LL, Calatzis AN, Feyh J, Hipp R, Hargasser SR. Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Acta Anaesthesiol Scand. 2000;44(9):1116-21.
Thyes C, Madjdpour C, Frascarolo P, Buclin T, Burki M, Fisch A, et al. Effect of high- and low-molecular-weight low-substituted hydroxyethyl starch on blood coagulation during acute normovolemic hemodilution in pigs. Anesthesiology. 2006;105(6):1228-37.
- Abstract Viewed: 287 times
- PDF Downloaded: 236 times